Publicacións nas que colabora con Ana Moya Álvarez (7)
2021
-
Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure
Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 953-961
2020
-
Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as corroborated by the Hygia Chronotherapy Trial. Rebuttal to European Society of Hypertension officials.
Chronobiology International, pp. 1-10
-
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial
European heart journal, Vol. 41, Núm. 48, pp. 4565-4576
2019
-
Asleep (not night-time) blood pressure as prognostic marker of cardiovascular risk
European Heart Journal
2018
-
Asleep blood pressure: Significant prognostic marker of vascular risk and therapeutic target for prevention
European Heart Journal, Vol. 39, Núm. 47, pp. 4159-4171
2013
-
Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes
Chronobiology International, Vol. 30, Núm. 1-2, pp. 99-115
-
Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension
Chronobiology International, Vol. 30, Núm. 1-2, pp. 192-206